16 December 2016 - Deborah Wilkes
Archived
Switzerland's Lonza Group is acquiring the drug-delivery specialist Capsugel from private-equity firm KKR in a deal worth USD5.5 billion in cash, including refinancing of existing Capsugel debt of USD2.0 billion.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.